ATE341559T1 - Verfahren zur herstellung von clarithromycin - Google Patents

Verfahren zur herstellung von clarithromycin

Info

Publication number: ATE341559T1
Authority: AT; Austria
Prior art keywords: oxide; clarithromycin; methylerythromycin; producing clarithromycin; producing
Prior art date: 1999-11-24

Application number

AT00981874T

Other languages

English (en)

Inventor

Kwee Hyun Suh

Mi Ra Seong

Nam Du Kim

Gwan Sun Lee

Original Assignee

Hanmi Pharm Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-24

Filing date

2000-11-23

Publication date

2006-10-15

2000-11-23 Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE341559T1 publication Critical patent/ATE341559T1/de

Links

229960002626 clarithromycin Drugs 0.000 title abstract 4
AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
-1 6-O-methylerythromycin A N-oxide Chemical class 0.000 abstract 2
LUIPOVCSQJTWHA-RWJQBGPGSA-N (2s,3r,4s,6r)-2-[[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-n,n,6-trimethyloxan-4-amine oxide Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)[N+](C)(C)[O-])O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 LUIPOVCSQJTWHA-RWJQBGPGSA-N 0.000 abstract 1
239000003638 chemical reducing agent Substances 0.000 abstract 1
239000012022 methylating agents‎ Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT00981874T 1999-11-24 2000-11-23 Verfahren zur herstellung von clarithromycin ATE341559T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR1019990052371A KR100336447B1 (ko)	1999-11-24	1999-11-24	클라리스로마이신의 개선된 제조방법

Publications (1)

Publication Number	Publication Date
ATE341559T1 true ATE341559T1 (de)	2006-10-15

Family

ID=19621549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00981874T ATE341559T1 (de)	1999-11-24	2000-11-23	Verfahren zur herstellung von clarithromycin

Country Status (14)

Country	Link
US (1)	US6809188B1 (de)
EP (1)	EP1232171B1 (de)
JP (1)	JP4040877B2 (de)
KR (1)	KR100336447B1 (de)
CN (1)	CN1399642A (de)
AT (1)	ATE341559T1 (de)
AU (1)	AU755838C (de)
BR (1)	BR0015780A (de)
CA (1)	CA2391145A1 (de)
DE (1)	DE60031154T2 (de)
ES (1)	ES2272342T3 (de)
RU (1)	RU2225413C1 (de)
TR (1)	TR200201382T2 (de)
WO (1)	WO2001038340A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100336447B1 (ko) *	1999-11-24	2002-05-15	민경윤	클라리스로마이신의 개선된 제조방법
AU2578701A (en) *	2000-02-29	2001-09-12	Teva Pharma	Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
EP1638549A4 (de)	2003-03-10	2011-06-15	Optimer Pharmaceuticals Inc	Neue antibakterielle mittel
WO2005000233A2 (en) *	2003-06-23	2005-01-06	Auspex Pharmaceuticals	Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
EP2023721A2 (de) *	2006-06-05	2009-02-18	Auspex Pharmaceuticals Inc.	Herstellung und verwendung substituierter erythromycin-analoge
CA2703475A1 (en) *	2007-10-25	2009-04-30	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) *	2008-10-24	2014-08-05	Cempra Pharmaceuticals, Inc.	Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja)	2009-09-10	2016-05-11	センプラファーマシューティカルズ，インコーポレイテッド	マラリア、結核、及びｍａｃ病の治療方法
CN103080122A (zh)	2010-03-22	2013-05-01	森普拉制药公司	大环内脂的结晶形式及其用途
WO2011146829A1 (en)	2010-05-20	2011-11-24	Cempra Pharmaceuticals, Inc.	Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja)	2010-09-10	2016-12-14	センプラファーマシューティカルズ，インコーポレイテッド	疾患治療のための水素結合形成フルオロケトライド
CN104470527B (zh)	2012-03-27	2019-05-28	森普拉制药公司	用于施用大环内酯抗生素的肠胃外制剂
RU2015138796A (ru)	2013-03-14	2017-04-19	Семпра Фармасьютикалс, Инк.	Способы и составы для лечения респираторных заболеваний
WO2014145210A1 (en)	2013-03-15	2014-09-18	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents
CN103172686B (zh) *	2013-04-08	2015-06-24	山东大学	克拉霉素-n-氧化物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI9011409A (en) *	1990-07-18	1995-10-31	Pliva Pharm & Chem Works	O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5872229A (en) *	1995-11-21	1999-02-16	Abbott Laboratories	Process for 6-O-alkylation of erythromycin derivatives
US5858986A (en) *	1996-07-29	1999-01-12	Abbott Laboratories	Crystal form I of clarithromycin
US5864023A (en) *	1997-02-13	1999-01-26	Abbott Laboratories	3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
IL135792A0 (en) *	1997-12-01	2001-05-20	Abbott Lab	6-o-alkyl derivatives of erythronolide b
US5892008A (en) *	1997-12-16	1999-04-06	Abbott Laboratories	Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100336447B1 (ko) *	1999-11-24	2002-05-15	민경윤	클라리스로마이신의 개선된 제조방법
KR20000037126A (ko) *	2000-04-08	2000-07-05	김용규	6-메틸 에리스로마이신 ａ의 제조방법

1999
- 1999-11-24 KR KR1019990052371A patent/KR100336447B1/ko not_active Expired - Fee Related
2000
- 2000-11-23 CA CA002391145A patent/CA2391145A1/en not_active Abandoned
- 2000-11-23 TR TR2002/01382T patent/TR200201382T2/xx unknown
- 2000-11-23 EP EP00981874A patent/EP1232171B1/de not_active Expired - Lifetime
- 2000-11-23 ES ES00981874T patent/ES2272342T3/es not_active Expired - Lifetime
- 2000-11-23 US US10/129,419 patent/US6809188B1/en not_active Expired - Fee Related
- 2000-11-23 JP JP2001540103A patent/JP4040877B2/ja not_active Expired - Fee Related
- 2000-11-23 RU RU2002116698/04A patent/RU2225413C1/ru not_active IP Right Cessation
- 2000-11-23 AU AU18983/01A patent/AU755838C/en not_active Ceased
- 2000-11-23 DE DE60031154T patent/DE60031154T2/de not_active Expired - Fee Related
- 2000-11-23 CN CN00816126A patent/CN1399642A/zh active Pending
- 2000-11-23 AT AT00981874T patent/ATE341559T1/de not_active IP Right Cessation
- 2000-11-23 BR BR0015780-5A patent/BR0015780A/pt not_active IP Right Cessation
- 2000-11-23 WO PCT/KR2000/001349 patent/WO2001038340A1/en not_active Ceased

Also Published As

Publication number	Publication date
JP4040877B2 (ja)	2008-01-30
DE60031154D1 (de)	2006-11-16
DE60031154T2 (de)	2007-01-11
EP1232171A4 (de)	2002-10-31
WO2001038340A1 (en)	2001-05-31
CA2391145A1 (en)	2001-05-31
ES2272342T3 (es)	2007-05-01
EP1232171B1 (de)	2006-10-04
EP1232171A1 (de)	2002-08-21
KR20010047939A (ko)	2001-06-15
CN1399642A (zh)	2003-02-26
TR200201382T2 (tr)	2002-10-21
RU2225413C1 (ru)	2004-03-10
JP2003514915A (ja)	2003-04-22
BR0015780A (pt)	2002-07-23
AU1898301A (en)	2001-06-04
AU755838C (en)	2004-07-08
AU755838B2 (en)	2002-12-19
US6809188B1 (en)	2004-10-26
KR100336447B1 (ko)	2002-05-15

Legal Events

Date	Code	Title	Description
2007-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60031154D1 (de)	2006-11-16	Verfahren zur herstellung von clarithromycin
BRPI0012198B8 (pt)	2021-05-25	anticorpos humanizados, composição e imunoconjugado
ATE294809T1 (de)	2005-05-15	Verfahren zur herstellung von 6-o-alkenyl- subsitutierten erythromycin-derivativen
ATE297941T1 (de)	2005-07-15	Verfahren zur herstellung von einer kristallinen form ii von clarythromycin
ATE288758T1 (de)	2005-02-15	Verfahren zur herstellung von polymorphen des clarithromycins
ATE195555T1 (de)	2000-09-15	Verfahren zur herstellung transformierter zellen
TW200801030A (en)	2008-01-01	Methods of producing C-aryl glucoside SGLT2 inhibitors
ID25613A (id)	2000-10-19	Metode untuk menghasilkan purin nukleosida melalui fermentasi
DE69217491D1 (de)	1997-03-27	Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
DE69728420D1 (de)	2004-05-06	Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten
FI872580A7 (fi)	1987-12-12	Menetelmä meripihkahapon valmistamiseksi anaerobisen käymisen avulla.
ATE232210T1 (de)	2003-02-15	Verfahren zur herstellung von erythromicin a-oxim
TR200000099T1 (tr)	2000-11-21	Üzüm için yenilenme sistemi ve kullanımı.
ATE232211T1 (de)	2003-02-15	Verfahren zur herstellung von form ii kristallen des clarithromycins
PL365176A1 (en)	2004-12-27	O-aryl glucoside sglt2 inhibitors and method
DE69812478D1 (de)	2003-04-30	Verfahren zum herstellen von gebogenen und gehärteten Glassscheiben und Vorrichtung zu Ihrer Herstellung
DE50113420D1 (de)	2008-02-07	Verfahren zur herstellung einer solarzelle und nach diesem verfahren hergestellte solarzelle
DE60025905D1 (de)	2006-04-20	In vitro methode zur synchronisation von oozytenreifung
EP1642970A4 (de)	2007-04-11	Verfahren zur herstellung eines transgenen organismus unter verwendung von methylierung und system dafür
DE3781878D1 (de)	1992-10-29	Antibiotikum-a10255-komplex und faktoren, verfahren, mikroorganismen fuer seine herstellung.
ATE266037T1 (de)	2004-05-15	Verfahren zur herstellung von phoshphorothioate triestere
DE50006669D1 (de)	2004-07-08	Verfahren und Vorrichtung zur Herstellung innenvergüteter Glasrohre
DE69416325D1 (de)	1999-03-11	Enzymatisches verfahren zur herstellung von morphin-6-glucuroniden oder substituierten morphin-6-glucuroniden
NO20015285D0 (no)	2001-10-29	Fremstillingsprosess for n¶ringsmiddelfermenterende midler
AU2001254864A1 (en)	2001-10-30	Cell culture method, cell cluster obtained by said methods and use thereof